Does ORELABRUTINIB Cause Off label use? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Off label use have been filed in association with ORELABRUTINIB. This represents 4.6% of all adverse event reports for ORELABRUTINIB.
6
Reports of Off label use with ORELABRUTINIB
4.6%
of all ORELABRUTINIB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Off label use From ORELABRUTINIB?
Of the 6 reports, 1 (16.7%) resulted in death, 2 (33.3%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ORELABRUTINIB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ORELABRUTINIB Cause?
Anaemia (54)
Hypokalaemia (40)
Pneumonia (35)
Neutropenia (30)
Thrombocytopenia (26)
Disease progression (14)
Covid-19 (11)
Platelet count decreased (11)
Drug ineffective (10)
Myelosuppression (10)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ORELABRUTINIB Alternatives Have Lower Off label use Risk?
ORELABRUTINIB vs ORENCIA
ORELABRUTINIB vs ORITAVANCIN
ORELABRUTINIB vs ORITAVANCIN DIPHOSPHATE
ORELABRUTINIB vs ORLISTAT
ORELABRUTINIB vs ORNIDAZOLE